Magle Group Announces Appointment of Distributor for SmartPAN® in Singapore

Magle Group, through its subsidiary Magle PharmaCept, is excited to announce the appointment of a new distributor for SmartPAN® in Singapore. This strategic partnership represents a pivotal step in our efforts to introduce SmartPAN® to the Asian market, underlining our commitment to improving pancreatic surgery outcomes globally.

Regulatory approval for SmartPAN® in Singapore is currently underway, with a registration period anticipated to be completed within eight weeks. This approval will accelerate our efforts to bring SmartPAN® to healthcare providers and patients in Singapore, enhancing the quality of surgical care in the region.

Helena Ossmer Thedius, Chief Marketing and Innovation Officer at Magle Group, commented, “We are delighted to partner with a reputable distributor in Singapore to introduce SmartPAN® to the market. The ongoing regulatory approval process is a significant milestone, and we anticipate a swift registration period. This strategic step aligns with our mission to expand our footprint in Asia and offer innovative solutions that enhance patient outcomes. By bringing SmartPAN® to Singapore, we are advancing our vision of improving surgical care through innovative technology.”

Check out the press release here